Cyveillance Outlines Best Practices for Combating Illegal Online Pharmaceutical Distribution
ARLINGTON, Va. –(Business Wire)– June 19, 2006 — Cyveillance, the leading provider of online risk monitoring and management solutions, today announced the availability of "Combating Illegal Online Distribution of Pharmaceuticals: Best Practices for the Pharmaceutical Industry," a new research paper available at: www.cyveillance.com/pharma.
The Wall Street Journal reports that illegal sales cost the pharmaceutical industry about $46 billion a year, to say nothing of the serious, often deadly consequences of ingesting uncontrolled and counterfeit substances. As part of Cyveillance's mission to educate users on how to identify and address online threats, the company is providing companies with the information and tools required to reduce the impact to their business, while also addressing the larger public health issue posed by counterfeit drugs and medicine obtained outside a doctor's prescription.